Á lódáil...
Characterizing expanded access and compassionate use programs for experimental drugs
OBJECTIVE: We sought to determine the characteristics of “expanded access” and “compassionate use” programs registered in ClinicalTrials.gov and to determine the percentage of drugs provided through these programs that ultimately received FDA marketing approval. RESULTS: We identified 398 expanded a...
Na minha lista:
| Foilsithe in: | BMC Res Notes |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5534121/ https://ncbi.nlm.nih.gov/pubmed/28754150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-017-2687-5 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|